NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Year-over-year net income growth rate
Percentile
P8
Near historical low
vs 3Y Ago
-7.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -70.78% |
| Q3 2025 | 7.84% |
| Q2 2025 | 18.22% |
| Q1 2025 | 205.71% |
| Q4 2024 | -80.36% |
| Q3 2024 | 1.32% |
| Q2 2024 | 73.05% |
| Q1 2024 | 81.62% |
| Q4 2023 | -42.36% |
| Q3 2023 | -12.21% |
| Q2 2023 | 52.39% |
| Q1 2023 | 342.70% |
| Q4 2022 | 9.68% |
| Q3 2022 | -82.27% |
| Q2 2022 | 734.46% |
| Q1 2022 | -162.81% |
| Q4 2021 | 23.50% |
| Q3 2021 | -13.20% |
| Q2 2021 | 41.51% |
| Q1 2021 | -15.47% |
| Q4 2020 | -69.02% |
| Q3 2020 | 64.82% |
| Q2 2020 | 30.50% |
| Q1 2020 | -9.95% |
| Q4 2019 | -12.18% |
| Q3 2019 | -16.90% |
| Q2 2019 | 18.54% |
| Q1 2019 | -24.26% |
| Q4 2018 | -12.60% |
| Q3 2018 | 0.50% |
| Q2 2018 | -39.45% |
| Q1 2018 | 37.89% |
| Q4 2017 | 156.49% |
| Q3 2017 | -9.79% |
| Q2 2017 | -46.81% |
| Q1 2017 | -9.41% |
| Q4 2016 | 193.13% |
| Q3 2016 | 39.66% |
| Q2 2016 | -23.33% |
| Q1 2016 | 67.29% |